Claims
- 1. An indazole compound which is selected from the group consisting of
- N-[2-(4-n-butyl-1-piperazinyl)ethyl]-1-n-propylindazole-3-carboxamide,
- N-[2-(4-butyl-1-piperazinyl)ethyl]-1-isopropylindazole-3-carboxamide, and
- N-[2-(4-n-pentyl-1-piperazinyl)ethyl]-1-n-propylindazole-3-carboxamide, or a pharmaceutically acceptable salt of any of the above.
- 2. The indazole compound of claim 1, which is N-[2-(4-n-butyl-1-piperazinyl)ethyl]-1-n-propylindazole-3-carboxamide, or a salt thereof.
- 3. The indazole compound of claim 1, which is N-[2-(4-butyl-1-piperazinyl)ethyl]-1-isopropylindazole-3-carboxamide, or a salt thereof.
- 4. The indazole compound of claim 1, which is N-[2-(4-p-methoxybenzyl-1-piperazinyl)ethyl]-1-n-propylindazole-3-carboxamide, or a salt thereof.
- 5. The indazole compound of claim 1, which is N-[2-(4-n-pentyl-1-piperazinyl)ethyl]-1-n-propylindazole-3-carboxamide, or a salt thereof.
- 6. A 5-HT.sub.4 receptor agonist composition, which comprises as an active ingredient, one or more compounds of claim 1, or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier.
- 7. The 5-HT.sub.4 receptor agonist composition of claim 6, which further contains one or more pharmaceutically acceptable additives.
Priority Claims (2)
Number |
Date |
Country |
Kind |
7-155493 |
May 1995 |
JPX |
|
8-35739 |
Jan 1996 |
JPX |
|
Parent Case Info
This application is a Division of application Ser. No. 08/952,509 filed on Nov. 28, 1997 now U.S. Pat. No. 5,945,434, which was filed as PCT International application as PCT/JP96/01475 on May 31, 1996.
US Referenced Citations (3)
Number |
Name |
Date |
Kind |
3145215 |
Kirchner |
Aug 1964 |
|
5654320 |
Catlow et al. |
Aug 1997 |
|
5684003 |
Kikuchi et al. |
Nov 1997 |
|
Divisions (1)
|
Number |
Date |
Country |
Parent |
952509 |
|
|